Nicolas Gendron: From HIT to VITT
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared a post on LinkedIn:
”From HIT to VITT-like syndromes: an overview of immune thrombocytopenias linked to anti-PF4 antibodies
Very pleased to announce the publication of our synthesis in La Revue du Praticien: “From heparin-induced thrombocytopenia to the emergence of immune thrombotic thrombocytopenia syndromes associated with anti-PF4 antibodies”
This work, carried out with Manon Jouffroy and David Smadja, traces the evolution of knowledge on thrombotic syndromes mediated by anti-PF4 antibodies, from HIT to the emergence of VITT (post-vaccine) and VITT-like (acute “infectious” or chronic, as we recently described in the NEJM Group).
We detail the pathophysiological, diagnostic and therapeutic aspects of these rare but important entities for the understanding of immunothrombosis mediated by anti-PF4 antibodies.”
Read the full article here.
Article: From heparin-induced thrombocytopenia to the emergence of immune thrombotic thrombocytopenia syndromes
Authors: Manon Jouffroy, David M. Smadja, Nicolas Gendron
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke
-
Jan 8, 2026, 05:11Thomas Meinel Shares The English Stroke Guidelines 2026
-
Jan 8, 2026, 05:03Hilla Ben-Pazi: We Were Pleased to Receive a Grant from the Israeli Ministry of Economy
-
Jan 8, 2026, 04:24Nikhil Agrawal Breaks Down Perioperative Anticoagulation
-
Jan 8, 2026, 03:58Louise St Germain Bannon Appointed Interim Executive Director of ISTH
-
Jan 8, 2026, 03:47Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
-
Jan 8, 2026, 03:28Rick Matthews: Powerful Perspective from Erin and the NBCA Team